Stock Events

Stock Events

Aktis Oncology (AKTS) Q3 2024 Earnings

8OctConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-1.14

-0.79

-0.45

-0.1

Details

Expected EPS

-0.1

Actual EPS

-1.14

Surprise EPS

-1.04

Surprise Percent

+1,040%

Description

Aktis Oncology (AKTS) has reported earnings of -1.14 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.